Ep0215 119 — Seattle, Washington

Ep0215 119 is a clinical research site located in Seattle, Washington, United States 98105.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Ep0215 119 has participated in 1 clinical trials.

Therapeutic areas: Dravet Syndrome, Lennox Gastaut Syndrome, Epileptic Encephalopathy.

Sponsors: Zogenix, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Seattle

Browse all research sites in Washington · View every site in Seattle

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ep0215 119?

Ep0215 119 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ep0215 119 conducted?

Ep0215 119 has 1 clinical trials on record. Their work covers Dravet Syndrome, Lennox Gastaut Syndrome, Epileptic Encephalopathy.

Is Ep0215 119 accredited by Crixeo Clinical Trials?

Ep0215 119 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Ep0215 119?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.